Comparison between Mono Pharmacare IPO and Shoora Designs IPO.
IPO Details
Mono Pharmacare IPO is a SME Fixed Price IPO proposed to list at NSE SME while Shoora Designs IPO is a SME Fixed Price proposed to list at BSE SME.
Issue Size and Price
The total issue size of Mono Pharmacare IPO is up to ₹14.07 Cr whereas the issue size of the Shoora Designs IPO is up to ₹1.90 Cr. The final issue price of Mono Pharmacare IPO is ₹28.00 per share and of Shoora Designs IPO is ₹48.00 per share.
IPO Timetable
Mono Pharmacare IPO opens on Aug 28, 2023, while Shoora Designs IPO opens on Aug 17, 2023. The closing date of Mono Pharmacare IPO and Shoora Designs IPO is Aug 30, 2023, and Aug 21, 2023, respectively.
| | Mono Pharmacare IPO | Shoora Designs IPO |
|---|
| Issue Open | Aug 28, 2023 | Aug 17, 2023 |
| Issue Close | Aug 30, 2023 | Aug 21, 2023 |
| Basis Of Allotment (Tentative) | Sep 04, 2023 | Aug 24, 2023 |
| Initiation of Refunds (Tentative) | Sep 05, 2023 | Aug 25, 2023 |
| Credit of Share (Tentative) | Sep 06, 2023 | Aug 28, 2023 |
| Listing date (Tentative) | Sep 07, 2023 | Aug 29, 2023 |
Financials & KPIs
Mono Pharmacare IPO P/E ratio is , as compared to Shoora Designs IPO P/E ratio of 35.82.
Shares Offered
In the Mono Pharmacare IPO Retail Individual Investors (RII) are offered 22,64,000 shares while in Shoora Designs IPO retail investors are offered 22,64,000 shares. Qualified Institutional Buyers (QIB) are offered 5,00,000 shares in Mono Pharmacare IPO and in Shoora Designs IPO.
| | Mono Pharmacare IPO | Shoora Designs IPO |
|---|
| Market Maker Reservation | 2,76,000 shares | 27,000 shares |
| QIB | 5,00,000 shares | |
| NII | 22,60,000 shares | 1,98,000 shares |
| RII | 22,64,000 shares | 1,98,000 shares |
| Total | 50,24,000 shares | 3,96,000 shares |
Bids Received (Subscription)
Mono Pharmacare IPO subscribed 13.42x in total, whereas Shoora Designs IPO subscribed 64.20x.
